PAC

Regimen

• Cisplatin 50 mg/m2 iv d1
• Doxorubicin (Adriamycin) 50 mg/m2 iv d1
• Cyclophosphamide (Cytoxan) 500 mg/m2 iv d1
• Q3w

References

Loehrer, PJ et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrenc thymoma: final results of an Intergroup trial. J Clin Oncol 1994; 12:1164